Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06403670
Status:
COMPLETED
Last Update Posted:
2024-05-08
First Post:
2024-05-01
Brief Title:
Dexmedetomidine and Remifentanil in NORA
Sponsor:
Baskent University Ankara Hospital
Organization:
Baskent University Ankara Hospital
Study Overview
Official Title:
The Effects of Dexmedetomidine and Remifentanil on Sedation and Comfort in Non-Operating Room Anesthesia A Randomized Double-blind Controlled Trial
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Endoscopic retrograde cholangiopancreatography ERCP procedure is frequently encountered in non-operating room anesthesia applications NORA It is a procedure that requires deep sedation and analgesia in terms of gastroenterologist and patient comfort Dexmedetomidine which is increasingly used in NORA applications comes to the fore because it does not cause respiratory depression reduces the stress response and provides hemodynamic stability This study aims to compare the effects of dexmedetomidine-propofol DP and remifentanil-propofol RP combinations on hemodynamic stability rapid recovery and patient comfort in patients who underwent ERCP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None